Area under the curve of tacrolimus using microsampling devices: towards precision medicine in solid organ transplantation?

Purpose Therapeutic drug monitoring of tacrolimus using trough concentration (C min ) is mandatory to ensure drug efficacy and safety in solid organ transplantation. However, C min is just a proxy for the area under the curve of drug concentrations (AUC) which is the best pharmacokinetic parameter for exposure evaluation. Some studies suggest that patients may present discrepancies between these two parameters. AUC is now easily available through mini-invasive microsampling approach. The aim of this study is to evaluate the relationship between AUC and C min in patients benefiting from a complete pharmacokinetic profile using a microsampling approach. Methods Fifty-one transplant recipients benefited from a complete pharmacokinetic profile using a microsampling approach, and their 24-h AUC were calculated using the trapezoidal method. The correlation with C min was then explored. In parallel, we estimated AUC using the sole C min and regression equations according to the post-transplantation days and the galenic form. Results Weak correlations were found between 24-h AUC observed and the corresponding C min ( R 2 = 0.60) and between AUC observed and expected using the sole C min ( R 2 = 0.62). Therapeutic drug monitoring of tacrolimus using C min leads to over- or under-estimate drug exposure in 40.3% of patients. Conclusion Tacrolimus C min appears to be an imperfect reflection of drug exposure. Evaluating AUC using a microsampling approach offers a mini-invasive strategy to monitor tacrolimus treatment in transplant recipients.